{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:33:57Z","timestamp":1753893237187,"version":"3.41.2"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Parotid gland adenocarcinoma not otherwise specified (PANOS) is a rare malignant tumor with limited data on its characteristics and prognosis. This research is aimed at characterizing PANOS and developing prognostic prediction models for patients with PANOS.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Cases from 2004\u20132016 were selected from the Surveillance, Epidemiology, and End Results (SEER) Program database. Univariate and multivariate Cox regression were applied to ascertain the factors associated with survival. Competing risk analysis and Gray's tests were employed to analyze cancer-specific death. Propensity score matching (1:1) was conducted to reduce the influence of confounding variables.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 446 patients with a median age of 66 years were selected, of which 307 were diagnosed with stage III\/IV PANOS. The 5-year overall survival (OS) rate of all patients was 51.8%, and the median survival time was 66 months. Surgical treatment clearly improved survival time (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). In the subgroup analysis, radiotherapy showed survival benefits in patients with stage III\/IV disease (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). Multivariate Cox regression analyses showed that age, T classification, N classification, M classification and surgery were independent prognostic indicators for OS; T classification, N classification, M classification and surgery were independent risk factors for cancer-specific survival (CSS). In addition, age was independently associated with other cause-specific death. Based on the results of multivariate analysis, two nomograms were developed and verified by the concordance index (C-index) (0.747 and 0.780 for OS and CSS) and the area under the time-dependent receiver operating characteristic (ROC) curve (0.756, 0.764, and 0.819 regarding for nomograms predicting 3-, 5-, and 10- year OS, respectively and 0.794, 0.789, and 0.806 for CSS, respectively).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Our study clearly presents the clinicopathological features and survival analysis of patients with PANOS. In addition, our constructed nomogram prediction models may assist physicians in evaluating the individualized prognosis and deciding on treatment for patients.<\/jats:p>","DOI":"10.3389\/fsurg.2021.799452","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T04:27:02Z","timestamp":1641875222000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishment and Validation of Prognostic Nomograms for Patients With Parotid Gland Adenocarcinoma Not Otherwise Specified: A SEER Analysis From 2004 to 2016"],"prefix":"10.3389","volume":"8","author":[{"given":"Zi-Meng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuo-Lin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/archotol.1991.01870150075010","article-title":"Primary parotid malignancies. a clinical and pathologic review","volume":"117","author":"Kane","year":"1991","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B2","first-page":"160","volume-title":"World Health Organization Classifcation Of Tumours. Chapter 7. Tumours Of Salivary Glands.","author":"El-Naggar","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1002\/cam4.3919","article-title":"Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: a population-based analysis","volume":"10","author":"Xu","year":"2021","journal-title":"Cancer Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e7237","DOI":"10.7717\/peerj.7237","article-title":"Nomogram to predict the prognosis of parotid gland mucoepidermoid carcinoma: a population-based study of 1306 cases","volume":"7","author":"Sun","year":"2019","journal-title":"PeerJ"},{"key":"B5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.amjoto.2017.03.008","article-title":"Parotid adenoid cystic carcinoma: retrospective single institute analysis","volume":"38","author":"Mannelli","year":"2017","journal-title":"Am J Otolaryngol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/cancers13040589","article-title":"Impact of tumor site and adjuvant radiotherapy on survival of patients with adenoid cystic carcinoma: a SEER database analysis","volume":"13","author":"Tasoulas","year":"2021","journal-title":"Cancers"},{"key":"B7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.semradonc.2012.03.009","article-title":"Biology and management of salivary gland cancers","volume":"22","author":"Adelstein","year":"2012","journal-title":"Semin Radiat Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.otohns.2005.08.001","article-title":"Clinical prognostic factors in malignant parotid gland tumors","volume":"133","author":"Lima","year":"2005","journal-title":"Otolaryngol Head Neck Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s10147-021-01901-3","article-title":"Symptoms and signs of parotid tumors and their value for diagnosis and prognosis: a 20-year review at a single institution","volume":"26","author":"Inaka","year":"2021","journal-title":"Int J Clin Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/lary.26055","article-title":"Laryngeal adenocarcinoma not otherwise specified: a population-based perspective","volume":"127","author":"Spinazzi","year":"2017","journal-title":"Laryngoscope."},{"key":"B11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00405-018-5224-9","article-title":"Clinical behaviours and prognoses of high- and low-risk parotid malignancies based on histology","volume":"276","author":"Tao","year":"2019","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12885-019-5564-x","article-title":"Salivary gland carcinoma in Shanghai (2003-2012): an epidemiological study of incidence, site and pathology","volume":"19","author":"Fu","year":"2019","journal-title":"BMC Cancer."},{"key":"B13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.oraloncology.2015.03.005","article-title":"Prognostic factors in adenocarcinoma of the salivary glands","volume":"51","author":"Huang","year":"2015","journal-title":"Oral Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.5858\/2004-128-1385-SANOSA","article-title":"Salivary adenocarcinoma, not otherwise specified: a collection of orphans","volume":"128","author":"Li","year":"2004","journal-title":"Arch Pathol Lab Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.oooo.2011.11.019","article-title":"Salivary adenocarcinoma, not otherwise specified: a clinicopathological study of 28 cases","volume":"113","author":"Deng","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2009.10.004","article-title":"Major and minor salivary gland tumors","volume":"74","author":"Guzzo","year":"2010","journal-title":"Crit Rev Oncol Hematol."},{"key":"B17","first-page":"625","article-title":"Surgical presentation and outcome of parotid gland tumours","volume":"23","author":"Shah","year":"2013","journal-title":"J Coll Physicians Surg Pak"},{"key":"B18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.otc.2015.11.001","article-title":"Diagnosis and management of malignant salivary gland tumors of the parotid gland","volume":"49","author":"Lewis","year":"2016","journal-title":"Otolaryngol Clin North Am."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.oraloncology.2015.10.002","article-title":"Salivary adenoid cystic carcinoma in Denmark 1990-2005: outcome and independent prognostic factors including the benefit of radiotherapy. results of the danish head and neck cancer group (DAHANCA)","volume":"51","author":"Bj\u00f8rndal","year":"2015","journal-title":"Oral Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijrobp.2004.03.018","article-title":"The role of radiotherapy in the treatment of malignant salivary gland tumors","volume":"61","author":"Terhaard","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jormas.2019.03.006","article-title":"Oncological outcomes of parotid gland malignancies: a retrospective analysis of 74 patients","volume":"120","author":"Molteni","year":"2019","journal-title":"J Stomatol Oral Maxillofac Surg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s10147-019-01489-9","article-title":"Development and validation of a nomogram containing the prognostic determinants of chondrosarcoma based on the surveillance, epidemiology, and end results database","volume":"24","author":"Zhang","year":"2019","journal-title":"Int J Clin Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1200\/JCO.2014.56.6661","article-title":"Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer","volume":"33","author":"Liang","year":"2015","journal-title":"J Clin Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol."}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2021.799452\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T15:50:40Z","timestamp":1703260240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2021.799452\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":24,"alternative-id":["10.3389\/fsurg.2021.799452"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2021.799452","relation":{},"ISSN":["2296-875X"],"issn-type":[{"type":"electronic","value":"2296-875X"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"article-number":"799452"}}